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Interactions of hypercholesterolemia and hypertension in initiation of
glomerular injury. In the DahI S rat (DS), salt induces systemic and
glomerular capillary hypertension associated with progressive glomer-
uloscierosis, while Dahi R rats (DR) remain normotensive, without
glomerular abnormalities. Studies in experimental models have sug-
gested that hypercholesterolemia may play a role in the development of
glomeruloscierosis; however, it is unclear whether hypercholesterol-
emia alone, in the absence of hypertension, can initiate injury. To
answer this question we induced hypercholesterolemia in salt-supple-
mented DS (DSC) and DR (DRC) by feeding a high cholesterol (4%)
chow. Control rats (DS, DR) received high-salt, normal cholesterol
chow. After eight weeks, DS and DSC developed equivalent hyperten-
sion (161 3 vs. 153 3 mm Hg, respectively, P NS), while DR and
DRC remained normotensive (138 S vs. 131 5 mm Hg, P NS; P
< 0.05 vs. DS and DSC). Cholesterol fed rats developed marked and
equivalent hypercholesterolemia compared to controls (DS vs. DSC, 71
3 vs. 289 91 mg/dl, P < 0.05; DR vs. DRC, 52 2 vs. 327 54
mgldl, P < 0.05). Hypertensive rats (DS, DSC) developed worse
proteinuria and glomerular injury than normotensive rats (DR, DRC),
but hypercholesterolemia exacerbated proteinuria and glomeruloscle-
rosis only in DSC and not in DRC. Proteinuria significantly correlated
with serum cholesterol in hypertensive rats (DS, DSC, P < 0.05), but
not normotensive rats (DR, DRC, P = NS). Furthermore, DSC had
increased renal vascular resistance compared to DS, while no differ-
ences were found between DRC and DR. Thus, in the DahI rat,
hypercholesterolemia alone does not initiate glomerular injury. In this
model, hypercholesterolemia is a pathogenetic factor in glomerular
injury only when it coexists with systemic hypertension.
Once established, chronic renal failure tends to be a progres-
sive disease eventually resulting in end-stage renal failure and
the need for renal replacement therapy [1, 21. To achieve the
ultimate goal of slowing or arresting the progression of renal
failure in patients, the mechanisms underlying this process must
be understood. Systemic hypertension complicates the course
of most patients with chronic renal failure [3] and is an
important pathogenetic factor in the progressive glomerular
injury that characterizes this process [4, 5]. However, diverse
mechanisms may underly this disease process [61, and other
factors may interact with hemodynamic forces to exacerbate
glomerular injury [7]. Recently, attention has focused on the
morphologic similarities between atherosclerosis and glomeru-
losclerosis, and it has been suggested that these two disease
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processes may share a common pathogenesis [8]. It follows
then, that as in atherosclerosis, hyperlipidemia may play a role
in the development of glomerular injury [91.
Studies in experimental models in rats [10—121 and guinea pigs
[13, 14] have suggested that hypercholesterolemia may contrib-
ute to the development of progressive glomerular injury. On the
other hand, Wantanabe rabbits with hereditary hyperlipemia
and monkeys given a high cholesterol diet develop pronounced
hypercholesterolemia and aortic atherosclerosis, but do not
develop glomerulosclerosis or proteinuria [15, 16]. However, in
these studies the contribution of elevated systemic blood pres-
sure or altered renal hemodynamics to the development of
glomerular injury was not systematically evaluated. Grone et a!
[17] demonstrated in a 2-kidney 1-clip model of hypertension in
the rat, that feeding a high fat, high cholesterol diet enhanced
glomeruloscierosis only in the unclipped kidney which was
presumably exposed to high systemic pressures. In the clipped
kidney, a high cholesterol diet did not effect the degree of
glomerular injury. These investigators concluded that adverse
glomerular hemodynamic alterations may be necessary for the
development of glomerulosclerosis in cholesterol fed rats. Har-
ris et al [18] investigated the development of glomerular injury
in a rat model of nephrotic syndrome induced by the injection of
puromycin and protamine. In this model, for significant glomer-
ular injury to develop in association with hypercholesterolemia,
it was necessary to superimpose the hemodynamic alterations
of uninephrectomy. Thus, it is possible that hypercholesterol-
emia alone may not initiate glomerular injury or does so only to
a very minor extent, but may act as an exacerbating factor in
the presence of coexistent glomerular capillary hypertension,
whether induced by reduction of functional renal mass or the
transmission of elevated systemic blood pressure to the glomer-
ulus.
To further investigate the possible interaction of hyperlipid-
emia and hypertension we performed experiments in the DahI
rat. The Dahl rat is derived from the Sprague-Dawley rat and
has been selectively bred to be either sensitive (DS) or resistant
(DR) to the pressor effect of chronic exposure to a high dietary
salt load [191. Furthermore, in the DS rat, the elevated systemic
blood pressure is freely transmitted to the glomerular capillaries
due to defective preglomerular autoregulation, resulting in
glomerular capillary hypertension [20]. This deranged renal
hemodynamic response to systemic hypertension has been
postulated to underly the marked susceptibility of the hyper-
tensive DS rat to progressive glomerular injury [21, 22]. The DR
1254
Tolins et a!: Cholesterol, hypertension and glomerular injury 1255
rat develops neither hypertension nor glomerular injury after
exposure to a high salt diet. In the current study, we utilized the
DS and DR rats to investigate the separate and combined effects
of hypertension and hypercholesterolemia on glomerular injury.
Methods
Experimental protocol
DahI S and DahI R rats (Brookhaven National Laboratories,
Brookhaven, New York, USA) were obtained at five to six
weeks of age, and after a two-week equilibration period on
regular rat chow (Purina Mills, St. Louis, Missouri, USA) were
divided into four groups and placed on experimental chows
(Teklad, Madison, Wisconsin, USA). DS rats (N = 10) were
provided a 6% NaC1 diet, while DSC rats (N = 10) received a
diet containing 6% NaC1, 4% cholesterol and 1% cholic acid.
DR rats (N = 5) were provided a 6% NaCI diet, while DRC rats
(N = 7) received a diet with 6% NaCI, 4% cholesterol and 1%
cholic acid. The diets were identical in protein content (20%) in
all experimental groups. Experimental diets and tap water were
provided ad libitum throughout the experimental protocol.
At baseline, and after 2, 4, 6 and 8 weeks on the experimental
diets, systolic blood pressure was measured by the tail-cuff
method in awake, restrained rats (Programmed Eiectro-Sphyg-
momanometer, Narco Bio-Systems, Houston, Texas, USA). At
baseline, 4 and 8 week old rats were placed in metabolic cages
for a 24-hour urine collection. Urinary total protein excretion
was assayed by the Coomassie dye method (Bio-Rad Labora-
tories, Richmond, California, USA). At baseline, after an
overnight fast, a tail vein blood sample was collected for
analysis of serum total cholesterol. At the end of the experi-
ment, after completion of clearance studies, a final blood
sample was obtained by exsanguination for determination of
cholesterol and lipoprotein characterization.
Lipoprotein separation and characterization
Blood was collected in sterile tubes and allowed to clot.
Serum was obtained by low speed centrifugation and treated
with disodium EDTA (4 mg/mI), sodium azide (4 mg/mi) and
gentamicin (62.5 g/ml). Very-low density lipoprotein (VLDL,
density < 1.006 g/ml) was isolated from serum (2 ml) by
ultracentrifugation in a Beckman TV- 100 rotor, and aspiration
of the resultant top layer by an adaptation of the method of
Chung et al [23]. The resultant infranatant (density > 1.006
g/ml) was harvested and the volume carefully measured. Total
cholesterol and triglycerides were measured on an aliquot of the
serum and infranatant as previously described [24]. High den-
sity lipoprotein (HDL) cholesterol was determined in the infra-
natant after low density lipoprotein (LDL) precipitation with
heparin-MnCI2 [24, 25]. LDL cholesterol was defined as the
difference in cholesterol concentration before and after heparin-
MnCI2 precipitation of the infranatant. VLDL cholesterol was
then calculated as the difference of the cholesterol content of an
aliquot of the serum and infranatant, For comparison purposes
all values were corrected to reflect the concentrations of
lipoprotein cholesterol in the original serum sample.
Clearance studies
After eight weeks on the experimental diets renal hemody-
namics were determined by clearance techniques as previously
described [22]. Rats were surgically prepared on a heated table
with rectal temperature maintained at 37°C. A tracheostomy
was performed after anesthesia (mactin, 100 mg/kg i.p.) and a
double-lumen PE-50 catheter placed in the internal jugular vein
for infusion. The left femoral artery was cannulated with a
PE-50 catheter for blood pressure monitoring (transducer model
TNf, Gould Inc., Oxnard, California, USA) and blood sam-
pling. The left ureter was cannulated with a PE-lO catheter and
timed urine samples collected in preweighed plastic vials for
gravimetric determination of urine flow rate. To determine GFR
and RPF, a solution of normal saline containing [3H-methoxy}-
inulin (4 Ci/ml) and para-aminohippurate (PAH, 20mg/mi) was
infused at a rate of 1.2 mi/hr after a priming dose of 0.5 ml. To
maintain euvolemia, 5% bovine serum albumin in normal saline
was given at 0.5 mI/hr after a priming dose of 1% of body
weight. Two 50 d blood samples were drawn at the midpoint of
each 20-minute clearance period. Radioactivity was determined
in serum and urine by liquid scintillation counting and PAH
levels in serum and urine were determined by autoanalyzer
(Technicon Corp., Tarrytown, New York, USA). GFR and
RPF were calculated by standard formulae. Renal blood flow
was calculated by dividing RPF by i-hematocrit and renal
vascular resistance (RVR) by dividing mean arterial pressure
(MAP) by RBF.
Morphology
After completion of clearance studies the kidneys were
removed, weighed and the tissue fixed by immersion in buffered
formaldehyde solution. Renal tissue was sectioned at 3 m and
stained with the periodic acid-Schiff technique. All tissues were
evaluated by a single investigator (L.R.) without knowledge of
the group to which the rat belonged. Glomerulosclerosis was
defined as the disappearance of cellular elements from the tuft,
collapse of capillary lumens, and folding of the glomerular
basement membrane with the entrapment of amorphous mate-
rial. A semiquantitative scoring technique evaluating the per-
centage of glomeruli with sclerosis and the extent of involve-
ment of each glomerulus was used as previously described [22,
26]. Mean glomerular volume for each sample was determined
by the point counting technique of Weibel 1271.
Statistical analysis
Data are presented as mean SEM. Parameters between
groups were compared by analysis of variance and subsequent
Scheffe's test. Parameters within one group at difference time
points were compared by analysis of variance for repeated
measures (STATVIEW 512, Brainpower Inc., Calabasas, Cal-
ifornia, USA). Differences were considered significant for P <
0.05.
Results
Rats tolerated the experimental diets well and all rats sur-
vived the duration of the experimental protocol. Physical and
biochemical parameters of the rats are shown in Table 1. As can
be seen, all rats gained weight and final body weights were not
different between the experimental groups. Hypertensive rats
(DS and DSC) tended to have larger kidneys than normotensive
rats (DR and DRC) but these differences did not reach statistical
significance. Cholesterol feeding did not influence whole kidney
Abbreviations are: wt, weight; Hct, hematocrit.
weight. Cholesterol fed rats developed marked hepatic enlarge-
ment and fatty infiltration (Fig. 1). No differences were found in
final hematocrit, serum protein or serum albumin concentra-
tions. Thus, feeding a high cholesterol diet did not effect the
overall growth or nutritional status of the rats during the course
of the experimental protocol.
As shown in Figure 2, over the eight weeks of the study, a
high salt diet induced equivalent systemic hypertension in
salt-sensitive rats (DS vs. DSC, 161 3 vs. 153 3 mm Hg, P
= NS), while salt-resistant rats remained normotensive (DR vs.
DRC,138±Svs. 131
DSC). Cholesterol-feeding per Se had no effect on systemic
blood pressure in either sensitive or resistant rats.
Initial and final total serum cholesterol levels are shown in
Figure 3. At baseline, there was no significant difference in total
serum cholesterol between DS and DSC (61.9 2.0 vs. 60.7
1.6 mgldl, P = NS) or between DR and DRC (52.0 0.5 vs. 50.9
0.6 mg/dl, P = NS). However, salt-sensitive rats had a
slightly, but statistically significant, higher level of cholesterol
at baseline than salt-resistant rats (P < 0.05). Cholesterol fed
rats developed marked and equivalent hypercholesterolemia by
eight weeks (DSC vs. DRC, 289.9 39.3 vs. 326.7 54.4, P
NS), while unsupplemented rats demonstrated no change in
serum cholesterol (DS vs. DR, 70.8 3.1 vs. 51.6 2.4 mg/dl,
P = NS,P < 0.05 vs. DSC or DRC). After eight weeks on a high
cholesterol diet, the distribution of total cholesterol between
VLDL, HDL, and LDL was similar in both groups of hyper-
cholesterolemic rats (DSC vs. DRC, VLDL: 72.6 2.4 vs. 73.2
5.3%, P NS; HDL: 5.3 1.0 vs. 5.8 1.2%, P = NS;
LDL: 22.2 2.5 vs. 15.9 3.2%, P NS). Cholesterol feeding
had no effect on serum triglycerides and final serum triglyceride
concentrations were similar in all experimental groups. Thus,
feeding a high cholesterol diet induced similar quantitative and
qualitative abnormalities in serum lipids in both salt-sensitive
and salt-resistant rats.
Urinary protein excretion rate at baseline, four and eight
weeks is shown in Figure 4. There were no significant differ-
ences in baseline proteinuria between any groups of rats (DS vs.
DSC, 27 4 vs. 28 4 mg/day, P = NS; DR vs. DRC, 14
vs. 18 I mg/day, P NS). However, salt-sensitive rats had
slightly, but not significantly, higher baseline levels of protein-
uria than salt-resistant rats. Over the course of the experiment
proteinuria did not change compared to baseline in normoten-
sive, DR or DRC, rats, nor was there any difference in urinary
protein excretion rates between DR or DRC rats at any time
point. As can be seen, both groups of hypertensive rats (DS,
DSC) developed progressive proteinuria over the course of the
experiment. Furthermore, at both four and eight weeks DSC
rats had a significantly higher urinary protein excretion rate
than DS rats. Linear regression analysis (Fig. 5) demonstrated
that in hypertensive rats urinary protein excretion rate was
significantly correlated (r = 0.78, P < 0.001) with serum
cholesterol level, while in normotensive rats proteinuria did not
correlate with serum cholesterol (r 0.57, P NS). Thus,
hypercholesterolemia exacerbated proteinuria only in the pres-
ence of coexisting hypertension.
Renal hemodynamic parameters are shown in Table 2.
Hypertensive rats (DS, DSC) tended to have a lower GFR than
normotensive rats (DR, DRC), but this difference was not
statistically significant. Cholesterol feeding per se did not effect
GFR. RPF was significantly reduced in DSC compared to DS,
whereas there was no difference in RPF between the two groups
of normotensive rats. DS and DR rats had a similar RPF, while
RPF in DSC was significantly reduced compared to DRC,
Hypertensive, hypercholesterolemic rats (DSC) demonstrated a
significant increase in RVR compared to hypertensive, normo-
cholesterolemic rats (DS), as well as compared to DR and DRC.
In normotensive rats, cholesterol feeding did not affect RVR
(DR vs. DRC, P NS). Thus, diet-induced hypercholesterol-
emia resulted in reduced RPF and renal vasoconstriction (in-
creased RVR) only in rats with coexisting hypertension.
As shown in Figure 6A, morphometric studies demonstrated
that hypertensive Dahl S rats had larger glomerular volumes
than normotensive DahI R rats (DS vs. DR, 2.05 0.09 vs. 1.50
0.08 sm3>< 106, P <0.05; DSC vs. DRC, 2.34 0.13 vs. 1.87
0.10 sm3 >< 10, P < 0.05). In hypertensive rats, hypercho-
lesterolemia was associated with an increase in glomerular
volume (DSC vs. DS, P <0.05). In normotensive rats, glomer-
ular volume also increased with cholesterol feeding but this
difference was not statistically significant (DRC vs. DR, P =
NS). Results of scoring of morphologic glomerular injury are
shown in Figure 6B. As can be seen, hypertensive rats had
more glomerular injury than normotensive rats regardless of
lipid status. However, in normotensive rats, hypercholesterol-
emia did not effect the degree of glomerular injury (DRC vs.
DR, 9 2 vs. 11 4, P NS). In contrast, in hypertensive
rats, hypercholesterolemia induced a significant increase in the
glomerular injury score (DSC vs. DS, 59 6 vs. 35 9, P <
0.05). Therefore, in the presence of hypertension, hypercholes-
terolemia markedly enhanced glomerular injury. In contrast,
hypercholesterolemia did not exacerbate glomerular injury
when the blood pressure was normal.
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Table 1. Physical and biochemical parameters of Dahi S (DS) and Dahi R (DR) rats on high (DSC, DRC) and normal (DS, DR)
cholesterol diets
Initial Final L.kidney Serum Serum
body wt body wt wt protein albumin
Group g gid!
Hct
DS (N = 10) 357 8 410 8 1.74 0.04 52 0.5 5.64 0.13 3.12 0.09
DSC(N = 10) 354 6 386 6 1.73 0.06 49 0.6 5.97 0.18 3.17 0.12
DR (N = 5) 335 21 392 18 1.64 0.11 48 1.0 5.54 0.14 3.16 0.09
DRC (N = 7) 384 20 396 16 1.63 0.05 47 0.3 6.14 0.18 3.36 0.10
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Fig. 1. Representative livers from Dahi S rats fed high cholesterol diet (4% cholestero!Il% cholic acid, left) or control diet (right) for 8 weeks.
Cholesterol feeding resulted in marked fatty infiltration and enlargement of the liver.
Discussion
Dahi S rats are genetically predisposed to the development of
systemic hypertension when exposed to a high salt diet, while
Dahi R rats, derived from the same original strain of rat, remain
normotensive when exposed to an equivalent dietary salt load
[19, 28}. Furthermore, with the development of systemic hyper-
tension, these rats develop glomerular hyperfiltration and hy-
perfusion associated with an increase in glomerular capillary
pressure [20]. These adverse hemodynamic adaptations to
systemic hypertension are felt to underlie the marked suscep-
tibility of Dahi S rats to the relatively rapid development of
progressive glomerular injury [7, 21]. An experimental design
using parallel groups of DS and DR rats exposed to a high salt
diet allows the investigator to observe the effects of manipula-
tions, such as the dietary induction of hypercholesterolemia, on
the development of glomerular injury in the presence or ab-
sence of systemic hypertension.
In the current study, comparison of DS and DR rats on
control diet allowed us to observe the effects of hypertension
alone on renal injury. While ingesting a diet with identical salt
and protein content, hypertensive DS rats developed a signifi-
cantly higher urinary protein excretion rate and glomerular
injury score compared to normotensive DR rats. These differ-
ences were accompanied by a tendency toward a greater whole
kidney weight and a significant increase in glomerular volume in
DS rats, but no difference in final serum cholesterol level.
Although not determined in the current study, it is likely that
free transmission of elevated systemic pressures to the glomer-
ular capillaries due to ineffective afferent arteriolar autoregula-
tion contributes to the enhanced injury observed in hyperten-
sive DS rats [20, 261. It has also recently been suggested that
renal and/or glomerular hypertrophy may contribute to progres-
sive glomerular injury independently of adaptive changes in
glomerular hemodynamics [29, 30]. Thus, the increase in gb-
merular volume in DS as compared to DR rats may also be
important in the development of gbomerular injury in DS rats.
The effect of hypercholesterolemia in the presence or ab-
sence of hypertension can be determined by comparing DSC
versus DS rats and DRC versus DR rats, respectively. Choles-
terol feeding per se did not affect the level of systemic blood
pressure in either R or S rats, and R and S rats developed
equivalent degrees of hypercholesterolemia. Thus, the effects
of hypercholesterolemia and hypertension on renal injury can
be considered independently in this study. In hypertensive rats,
diet induced hypercholesterolemia was associated with in-
creased proteinuria, and serum cholesterol level was signifi-
cantly correlated with urinary protein excretion rate. Further-
more, in hypertensive rats there was a significant increase in the
extent of gbomerulosclerosis in rats on a high cholesterol diet, In
contrast, in normotensive Dahi R rats diet-induced hypercho-
lesterolemia was not associated with an increase in proteinuria
nor an increase in glomerular injury score. It is clear from these
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Fig. 4. (Jrina,y protein excretion rate at baseline and after four and
eight weeks on experimental diets. Symbols are: (D) DS; (K1) DSC; (U)
DR; (•) DRC. * P < 0.05 DSC vs. DS or DRC vs. DR.
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Fig. 2. Awake systolic blood pressure in rats at baseline (0), and after
2,4 and8 weeks on experimental diets. Symbols are: (U) Dahi S rat; ()
Dahi S rat fed high cholesterol chow; (U) Dahi R rat; (•) Dahi R rat fed
high cholesterol chow. * P < 0.05 DS vs. DR or DSC vs. DRC.
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Fig. 3. Serum total cholesterol at baseline and after eight weeks on
experimental diets. Symbols are: (U) DS; () DSC; (U) DR; (•) DRC.P < 0.05 DSC vs. DS or DRC vs. DR.
data that in the Dahi rat, hypercholesterolemia, in the absence
of hypertension, does not initiate glomerular injury, at least
over the time course of the experimental protocol. It is possible
that if the experiment had been extended to a much longer time
course, a low grade effect of cholesterol alone might have
become manifest. On the other hand, it is quite clear that in the
presence of systemic, and most likely, intraglomerular, hyper-
tension, hyperlipidemia enhances glomerular injury. An analo-
gous finding in the pathogenesis of atherosclerosis was reported
by Chobanian et a! 3lI. These investigators observed that
hypertension, induced by unilateral renal artery clipping, accel-
erated aortic atherogenesis in Watanabe heritable hyperlipid-
emic rabbits, compared to rabbits with equivalent hyperlipemia
but normal blood pressure.
The current study thus suggests that for hyperlipidemia to be
an important pathogenetic factor in progressive glomerular
injury there must be coexisting adverse glomerular hemody-
a
0
a
r = 0.78
P< 0.0001
0 100 200 300
A Hypertensive DahI S rats
400
300
200
C
100
0
400 500 600
Serum cholesterol, mg/d/
B Normotensive DahI A rats
400
300
r=0.57
200 P=NS
100
0 -
0 100 200 300 400 500 600
Serum cholesterol, mg/d/
Fig. 5. Correlations between proteinuria and serum total cholesterol inhypertensive Dahl S rats (A) and normotensive DahI R rats (B).
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Table 2. Renal hemodynamic parameters in hypercholesterolemic Dahl S (DSC) and Dahi R (DRC) rats and normocholesterolemic
Dahi S (DS) and Dahi R (DR) rats
Group
MAP
mm Hg
GFR RPF RVR
mm
Hg minim!milminig kidney WI
DS (N = 10)
DSC (N = 10)
DR (N = 5)
DRC (N = 7)
153 4
141 3
133 5b
128 5'
0.88 0.05
0.86 0.06
0.90 0.08
0.95 0.03
2.56 0.2l
1.95 0.07
2.68 0.15
3.11 026b
17.70 1.52
21.61 3.25
16.33 1.94
13.83 106b
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular filtration rate; RPF, renal plasma flow; RVR, renal vascular resistance.
a P < 0.05 DS vs. DSC or DR vs. DRCb P < 0.05 DR vs. DS or DRC vs. DSC
Based on studies in rat models, several investigators [12, 17, 18]
have reported that uninephrectomy, a maneuver which induces
potentially adverse glomerular hemodynamic effects, was nec-
essary to see an adverse effect of hyperlipidemia or to enhance
a minor effect seen in intact animals. Kasiske eta! [11] reported
that in obese Zucker rats lowering of cholesterol with mevinolin
reduced renal injury, as did clofibric acid. However, in this
study, treatment with mevinolin was associated with a 15 mm
Hg decrease in systolic blood pressure while clofibric acid did
not effect blood pressure. Although both agents reduced serum
cholesterol to an identical extent, mevinolin reduced mesangial
expansion and glomerulosclerosis to a much greater extent than
clofibric acid. Thus, a major protective effect of pharmacologic
lowering of serum cholesterol was observed only when blood
pressure was also lowered, supporting the hypothesis that
hyperlipidemia must interact with hypertension to play a patho-
genetic role.
The mechanisms by which hyperlipidemia enhances hyper-
tensive glomerular injury are not elucidated by the current
study, however the renal functional studies do provide some
basis for speculation. In normotensive rats (DRC) cholesterol
feeding did not significantly affect renal hemodynamics as
determined by clearance techniques. However, in hypertensive
rats, hypercholesterolemia was associated with a significant
decrease in renal plasma flow and renal vasoconstriction as
reflected in a significant increase in renal vascular resistance.
Kaplan and coworkers [33] also demonstrated that short-term
cholesterol feeding in normal rats was associated with renal
vasoconstriction, perhaps due to increased levels of oxidized
LDL. Using micropuncture techniques these investigators re-
ported that the increase in renal vascular resistance was asso-
ciated with an increase in single-nephron filtration fraction and
glomerular capillary hypertension. These latter findings are
presumably explained by a predominant vasoconstrictor effect
of hypercholesterolemia on the post-glomerular or efferent
arterioles. This vasoconstrictor effect may in fact, be due to
impairment of endothelium-dependent vasodilatation. Exoge-
nous LDL has been demonstrated to impair endothelium-
dependent vasodilator responses in vitro [34, 35} and hypercho-
lesterolemia in rabbits in vivo has also been reported to impair
endothelium-dependent vasodilatation [36, 37]. Since it has
previously been shown that normocholesterolemic, hyperten-
sive Dahl S rats already have impaired vasodilator responses to
agonists of endothelium-derived relaxing factor [38], it is appar-
ent that the superimposition of hypercholesterolemia upon
A
— P<0.05
3
x
B
75
0 50
>-
C
25
0
DS DSC DR DRC
Fig. 6. Final glomerular volume (A) and final glomerular injury score
(B) after eight weeks on experimental diets. NS, not significant; other
abbreviations as in previous figures.
namic alterations. This has been suggested in previous studies
as well. Diamond and Karnovsky [32] noted an increase in renal
injury in cholesterol fed rats which had been made nephrotic
with puromycin aminonucleoside; but these cholesterol-fed rats
also demonstrated a significant increase in blood pressure.
P<O.05 —
—P< 0.05—
Pc 0.05
— P<0.05
—Pc 0.05 —
— PNS—
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hypertension in the Dab! rats could lead to further impairment
of endothelial function.
Abnormalities in endothelial function could have pathoge-
netic consequences as endothelium-derived relaxing factor has
recently been suggested to play an important role in the
regulation of renal hemodynamics [39]. When inhibitors of the
synthesis of endothelium-derived relaxing factor are infused
into the renal artery of the rat, a renal vasoconstrictor response
with a marked rise in filtration fraction is observed [401,
hemodynamic responses similar to those reported by Kaplan et
al [33j with cholesterol feeding. It is therefore possible that
hyperlipidemia induces endothelial dysfunction with subse-
quent renal vasoconstriction, especially of the efferent arteri-
oles. In the presence of systemic hypertension, this could result
in marked glomerular capillary hypertension and accelerated
glomerular injury. These potential interactions of hyperlipid-
emia, hypertension, endothelial function and renal hemody-
namics are an important area for future investigations.
Impairment of endothelial function by hypertension and
hyperlipidemia cou!d also have adverse non-hemodynamic ef-
fects on the kidney [411. EDRF inhibits platelet aggregation
[421, and has an anti-proliferative effect on glomerular mesan-
gia! cells [43, 441. Thus, impaired endothelial function could
result in enhanced thrombogenicity, proliferation of mesangial
cells and increased mesangial matrix production, all of which
could contribute to glomerular sclerosis, Furthermore, specific
binding and uptake of LDL has been demonstrated in mesangial
cells, resulting in direct effects on cellular proliferation and
injury [451. The relative importance of these non-hemodynamic
effects of hyperlipidemia and hypertension in the development
of glomerular injury remains unclear.
In summary, we have demonstrated that in the DahI rat,
diet-induced hypercholesterolemia results in enhanced glomer-
ular injury only in the presence of coexisting hypertension. In
this mode!, an effect of cholesterol-feeding alone on the devel-
opment of glomerular injury was not detected. We conclude
that while hyperlipidemia may be a cofactor in the pathogenesis
of progressive renal injury associated with systemic hyperten-
sion, it does not appear to have a significant independent role.
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